- Home
- Publications
- Publication Search
- Publication Details
Title
Hypertension and COVID-19: Current Evidence and Perspectives
Authors
Keywords
-
Journal
High Blood Pressure & Cardiovascular Prevention
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-02-20
DOI
10.1007/s40292-022-00506-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19
- (2021) Renato D. Lopes et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial
- (2021) Jordana B Cohen et al. Lancet Respiratory Medicine
- Renin–angiotensin-system inhibitors and all-cause mortality in patients with coronavirus disease 2019
- (2021) Chirag Bavishi et al. JOURNAL OF HYPERTENSION
- Hypertension, a Moving Target in COVID-19
- (2021) Carmine Savoia et al. CIRCULATION RESEARCH
- RAMIC: Design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19
- (2021) Veeral Ajmera et al. Contemporary Clinical Trials
- A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19
- (2021) Bhaskar Thakur et al. Scientific Reports
- A Contemporary View of Natriuretic Peptides in the SARS-CoV-2 Era
- (2021) Speranza Rubattu et al. Frontiers in Physiology
- Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial
- (2021) Axel Bauer et al. Lancet Respiratory Medicine
- Oxidative stress – A unifying paradigm in hypertension
- (2020) Rhian M. Touyz et al. CANADIAN JOURNAL OF CARDIOLOGY
- COVID-19 Does Not Lead to a “Typical” Acute Respiratory Distress Syndrome
- (2020) Luciano Gattinoni et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19
- (2020) Reinhold Kreutz et al. CARDIOVASCULAR RESEARCH
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- White Blood Cells and Blood Pressure
- (2020) Mateusz Siedlinski et al. CIRCULATION
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
- (2020) Behnood Bikdeli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study
- (2020) Francisco J de Abajo et al. LANCET
- Endothelial cell infection and endotheliitis in COVID-19
- (2020) Zsuzsanna Varga et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
- (2020) Giuseppe Mancia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
- (2020) Harmony R. Reynolds et al. NEW ENGLAND JOURNAL OF MEDICINE
- Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
- (2020) Annemarie B Docherty et al. BMJ-British Medical Journal
- Understanding pathways to death in patients with COVID-19
- (2020) Jean-Louis Vincent et al. Lancet Respiratory Medicine
- Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)
- (2020) Neil Mehta et al. JAMA Cardiology
- Cardiac Endotheliitis and Multisystem Inflammatory Syndrome After COVID-19
- (2020) Sharon E. Fox et al. ANNALS OF INTERNAL MEDICINE
- Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science
- (2020) Paul C Evans et al. CARDIOVASCULAR RESEARCH
- Age and Multimorbidity Predict Death Among COVID-19 Patients
- (2020) Guido Iaccarino et al. HYPERTENSION
- Renin-Angiotensin System Blockers and the COVID-19 Pandemic
- (2020) A.H. Jan Danser et al. HYPERTENSION
- 2020 International Society of Hypertension global hypertension practice guidelines
- (2020) Thomas Unger et al. JOURNAL OF HYPERTENSION
- The protein expression profile of ACE2 in human tissues
- (2020) Feria Hikmet et al. Molecular Systems Biology
- Covid-19 — Implications for the Health Care System
- (2020) David Blumenthal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases
- (2020) Diana Lindner et al. JAMA Cardiology
- Mas Receptor Activation Contributes to the Improvement of Nitric Oxide Bioavailability and Vascular Remodeling During Chronic AT1R (Angiotensin Type-1 Receptor) Blockade in Experimental Hypertension
- (2020) Carmine Savoia et al. HYPERTENSION
- Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection in South Korea
- (2020) Minkook Son et al. HYPERTENSION
- SARS-CoV-2 renal tropism associates with acute kidney injury
- (2020) Fabian Braun et al. LANCET
- ACE2 mouse models: a toolbox for cardiovascular and pulmonary research
- (2020) Hongpeng Jia et al. Nature Communications
- High systolic blood pressure at hospital admission is an important risk factor in models predicting outcome of COVID-19 patients
- (2020) Antoine Caillon et al. AMERICAN JOURNAL OF HYPERTENSION
- Potential protective effects of antihypertensive treatments during the Covid-19 pandemic: from inhibitors of the renin-angiotensin system to beta-adrenergic receptor blockers
- (2020) Sverre E. Kjeldsen et al. BLOOD PRESSURE
- Impact of arterial stiffness on all-cause mortality in patients hospitalized with COVID-19 in Spain
- (2020) Enrique Rodilla et al. HYPERTENSION
- Lifestyle, psychological, socioeconomic and environmental factors and their impact on hypertension during the coronavirus disease 2019 pandemic
- (2020) Reinhold Kreutz et al. JOURNAL OF HYPERTENSION
- Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19
- (2020) Saskia Trump et al. NATURE BIOTECHNOLOGY
- Counter-regulatory renin–angiotensin system in cardiovascular disease
- (2019) Maria Paz Ocaranza et al. Nature Reviews Cardiology
- Role of immune cells in hypertension
- (2018) Antoine Caillon et al. BRITISH JOURNAL OF PHARMACOLOGY
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
- (2018) Paul K. Whelton et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7)
- (2018) Robson Augusto Souza Santos et al. PHYSIOLOGICAL REVIEWS
- 2018 ESC/ESH Guidelines for the management of arterial hypertension
- (2018) Bryan Williams et al. EUROPEAN HEART JOURNAL
- Interaction Between Hypertension and Arterial Stiffness
- (2018) Michel E. Safar et al. HYPERTENSION
- Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension
- (2018) Shalini M Krishnan et al. CARDIOVASCULAR RESEARCH
- Divergent roles of endothelial nitric oxide synthases system in maintaining cardiovascular homeostasis
- (2017) Shigeo Godo et al. FREE RADICAL BIOLOGY AND MEDICINE
- Microvascular Endothelial Dysfunction in Sedentary, Obese Humans Is Mediated by NADPH OxidaseHighlights
- (2016) Justin D. La Favor et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Activation of Human T Cells in HypertensionNovelty and Significance
- (2016) Hana A. Itani et al. HYPERTENSION
- From gene to protein—experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension
- (2014) Sheila K. Patel et al. Frontiers in Physiology
- Immunosenescent CD8 + T Cells and C-X-C Chemokine Receptor Type 3 Chemokines Are Increased in Human Hypertension
- (2013) Jong-Chan Youn et al. HYPERTENSION
- Angiotensin-converting enzyme 2 antagonizes angiotensin II-induced pressor response and NADPH oxidase activation in Wistar-Kyoto rats and spontaneously hypertensive rats
- (2012) Jennifer Lo et al. EXPERIMENTAL PHYSIOLOGY
- Angiotensin type 2 receptor in hypertensive cardiovascular disease
- (2011) Carmine Savoia et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Renal ACE2 expression and activity is unaltered during established hypertension in adult SHRSP and TGR(mREN2)27
- (2009) Jelena Kamilic et al. HYPERTENSION RESEARCH
- Transgenic Angiotensin-Converting Enzyme 2 Overexpression in Vessels of SHRSP Rats Reduces Blood Pressure and Improves Endothelial Function
- (2008) Brit Rentzsch et al. HYPERTENSION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started